120 related articles for article (PubMed ID: 14511998)
1. Long term prognosis in patients with peripheral arterial disease treated with antiplatelet agents.
Fiotti N; Altamura N; Cappelli C; Schillan M; Guarnieri G; Giansante C
Eur J Vasc Endovasc Surg; 2003 Oct; 26(4):374-80. PubMed ID: 14511998
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
3. Treatment of intermittent claudication with antiplatelet agents.
Giansante C; Calabrese S; Fisicaro M; Fiotti N; Mitri E
J Int Med Res; 1990; 18(5):400-7. PubMed ID: 2147914
[TBL] [Abstract][Full Text] [Related]
4. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
Hankey GJ; Sudlow CL; Dunbabin DW
Cochrane Database Syst Rev; 2000; (2):CD001246. PubMed ID: 10796426
[TBL] [Abstract][Full Text] [Related]
5. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
Cavendish JJ; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy in the prevention of ischaemic stroke.
Verry M; Panak E; Cazenave JP
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR;
N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717
[TBL] [Abstract][Full Text] [Related]
8. Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease.
Alcocer F; Novak Z; Combs BR; Lowman B; Passman MA; Mujib M; Jordan WD
J Vasc Surg; 2014 Apr; 59(4):950-5. PubMed ID: 24491238
[TBL] [Abstract][Full Text] [Related]
9. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
11. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy in the treatment of cerebrovascular disease.
Couch JR
Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy to prevent cardiovascular events and mortality in patients with intermittent claudication.
Wong PF; Chong LY; Stansby G
JAMA; 2013 Mar; 309(9):926-7. PubMed ID: 23462789
[TBL] [Abstract][Full Text] [Related]
14. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
15. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
Boissel JP
Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1721-4. PubMed ID: 1837446
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.
Han Y; Li Y; Wang S; Jing Q; Wang Z; Wang D; Shu Q; Tang X
Am Heart J; 2009 Apr; 157(4):733-9. PubMed ID: 19332203
[TBL] [Abstract][Full Text] [Related]
17. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy.
Hiatt WR
J Intern Med; 2002 Mar; 251(3):193-206. PubMed ID: 11886478
[TBL] [Abstract][Full Text] [Related]
18. Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke.
Ito E; Takahashi A; Yamamoto H; Kuzuhara S; Uchiyama S; Nakajima M;
Intern Med; 2003 Sep; 42(9):793-9. PubMed ID: 14518664
[TBL] [Abstract][Full Text] [Related]
19. Review of aspirin and clopidogrel resistance in peripheral arterial disease.
Guirgis M; Thompson P; Jansen S
J Vasc Surg; 2017 Nov; 66(5):1576-1586. PubMed ID: 28893489
[TBL] [Abstract][Full Text] [Related]
20. [Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
Diehm C; Lawall H; Huber R
Med Klin (Munich); 2004 Aug; 99 Suppl 1():14-20. PubMed ID: 15487853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
